This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Influenza A H6N1 Hemagglutinin (HA), C-His
Product Overview
BioVenic's Recombinant Influenza A H6N1 Hemagglutinin (HA), C-His is a recombinant protein expressed from HEK293 Cells. Its predicted molecular weight is 59.2 kDa. The purity is>90% (SDS-PAGE). The endotoxin level is <1 EU/μg (LAL).
Specifications
Target Information
H6N1 is a subtype of Influenza A virus (IAV). For avian influenza viruses to infect and become transmissible among humans, alterations in the receptor binding site (RBS) of their hemagglutinin (HA) protein are necessary, shifting receptor preference from α2-3-linked (avian-like) sialosides to α2-6-linked (human-like) sialosides.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store for 4 weeks at 2-8°C, for 12 months at -20°C or -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.